Aphex BioCleanse Systems Stock (OTC: SNST)

Latest news for Aphex BioCleanse Systems (OTC:SNST) Stock

Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.

SUNSET CAPITAL ASSETS INC by Sunset Capital Assets, Inc.

Aphex BioCleanse Systems Inc

News

TZUP

Thumzup Says Its Ad-Tech Platform Has Now Attracted Over 500 Advertisers

<p>Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) is gearing up to announce its quarterly earnings on Monday, 2024-11-25. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Alarum Technologies will report an <strong>earnings per share</strong> (EPS) of $0.04.</p>
<p>Alarum Technologies bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company beat EPS by $0.10, leading to a 8.56% drop in the share price the following trading session.</p>
<p>Here's a look at Alarum Technologies's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.31</td>
<td>0.28</td>
<td>0.25</td>
<td>0.07</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.41</td>
<td>0.23</td>
<td>0.30</td>
<td>0.03</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-9.0%</td>
<td>7.000000000000001%</td>
<td>-11.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284195_0.png" alt="eps graph" /></p>
<h3>Market Performance of Alarum Technologies's Stock</h3>
<p>Shares of Alarum Technologies were trading at $13.29 as of November 19. Over the last 52-week period, shares are up 143.85%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Opinions on Alarum Technologies</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Alarum Technologies.</p>
<p>Analysts have given Alarum Technologies a total of 1 ratings, with the consensus rating being Buy. The average one-year price target is $28.0, indicating a potential 110.68% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Duos Technologies Group, Silvaco Group and Telos, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Duos Technologies Group received a Buy consensus from analysts, with an average 1-year price target of $8.0, implying a potential 39.8% downside.</li>
<li>As per analysts' assessments, Silvaco Group is favoring an Buy trajectory, with an average 1-year price target of $20.71, suggesting a potential 55.83% upside.</li>
<li>The consensus outlook from analysts is an Buy trajectory for Telos, with an average 1-year price target of $4.75, indicating a potential 64.26% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Duos Technologies Group, Silvaco Group and Telos, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alarum Technologies</td>
<td>Buy</td>
<td>27.19%</td>
<td>$6.83M</td>
<td>-1.87%</td>
</tr>
<tr>
<td>Duos Technologies Group</td>
<td>Buy</td>
<td>111.57%</td>
<td>$919.10K</td>
<td>-52.24%</td>
</tr>
<tr>
<td>Silvaco Group</td>
<td>Buy</td>
<td>-26.58%</td>
<td>$8.19M</td>
<td>-6.53%</td>
</tr>
<tr>
<td>Telos</td>
<td>Buy</td>
<td>-34.28%</td>
<td>$3.14M</td>
<td>-20.14%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Alarum Technologies ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit and Return on Equity.</p>
<h3>Discovering Alarum Technologies: A Closer Look</h3>
<p>Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.</p>
<h3>Breaking Down Alarum Technologies's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Alarum Technologies displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>27.19%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Alarum Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-3.95%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Alarum Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>-1.87%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>-1.22%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Alarum Technologies's debt-to-equity ratio is below the industry average. With a ratio of <b>0.09</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/ALAR/earnings"><strong>To track all earnings releases for Alarum Technologies visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

ALAR

A Glimpse of Alarum Technologies's Earnings Potential

<p>On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said <strong>MicroStrategy Incorporated</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) is a Bitcoin play and he prefers to <a href="https://www.benzinga.com/quote/MSTR/analyst-ratings">actually own </a><strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).</p>
<p>MicroStrategy announced it completed its previously announced offering of its 0% convertible senior notes due 2029. MicroStrategy said the aggregate principal amount of the notes sold in the offering was $3 billion, which includes $400 million aggregate principal amount of notes issued pursuant to an option to purchase.</p>
<p>When asked about <strong>Oscar Health, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>), he said, &#8220;Until I saw that Mark Bertolini is the CEO, I didn't really have much in store for this. But Bertolini's a winner and a hitter.&#8221;</p>
<p>On Nov. 7, Oscar Health reported a quarterly loss of 22 cents per share which missed the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $2.42 billion which beat the analyst consensus estimate of $2.34 billion.</p>
<p><strong>CNH Industrial N.V.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNH#NYSE">CNH</a>) is a &#8220;second-rater,&#8221; Cramer said. &#8220;I want to go with best of breed, and best of breed is John <strong>Deere </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>).&#8221;</p>
<p>On Nov. 7, CNH Industrial reported worse-than-expected third-quarter EPS results and also lowered FY24 adjusted EPS outlook.</p>
<p>&#8220;The former, BGS, is a total loser and has been a loser for many, many years,&#8221; Cramer said when asked about <strong>B&amp;G Foods, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>).</p>
<p>On Nov. 5, B&amp;G Foods reported worse-than-expected third-quarter financial results and issued FY24 net sales guidance below estimates.</p>
<p>When asked about <strong>Rocket Lab USA, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>), he said, &#8220;It's moth to flame, but I don't know how close the moth is to the flame.&#8221;</p>
<p>On Nov. 19, Goldman Sachs analyst Noah Poponak maintained Rocket Lab with a Neutral and raised the price target from $5 to $12.</p>
<p><strong>Price Action:</strong></p>
<ul>
<li>Oscar Health shares fell 4.1% to settle at $16.31 on Thursday.</li>
<li>CNH Industrial shares gained 4.6% to close at $11.92.</li>
<li>Rocket Lab shares gained 11.1% to close at $22.41.</li>
<li>MicroStrategy shares fell 16.2% to settle at $397.28 during the session.</li>
</ul>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/24/11/42122978/wall-streets-most-accurate-analysts-weigh-in-on-3-defensive-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Long Ideas

Markets

Media

Trading Ideas

$BTC

MSTR

OSCR

RKLB

Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin

<p>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) is preparing to release its quarterly earnings on Monday, 2024-11-25. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect BioLine Rx to report an <strong>earnings per share</strong> (EPS) of $-0.10.</p>
<p>Anticipation surrounds BioLine Rx's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>During the last quarter, the company reported an EPS beat by $0.14, leading to a 8.88% increase in the share price on the subsequent day.</p>
<p>Here's a look at BioLine Rx's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.14</td>
<td>-0.29</td>
<td>-0.22</td>
<td>-0.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>-0.01</td>
<td>-0.15</td>
<td>-0.26</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>9.0%</td>
<td>-4.0%</td>
<td>8.0%</td>
<td>-11.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284187_0.png" alt="eps graph" /></p>
<h3>BioLine Rx Share Price Analysis</h3>
<p>Shares of BioLine Rx were trading at $0.32325 as of November 21. Over the last 52-week period, shares are down 77.86%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/BLRX/earnings"><strong>To track all earnings releases for BioLine Rx visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BLRX

Earnings Preview For BioLine Rx

<p>StealthGas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GASS#NASDAQ">GASS</a>) is preparing to release its quarterly earnings on Monday, 2024-11-25. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect StealthGas to report an <strong>earnings per share</strong> (EPS) of $0.33.</p>
<p>Anticipation surrounds StealthGas's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company beat EPS by $0.22, which was followed by a 1.61% drop in the share price the next day.</p>
<p>Here's a look at StealthGas's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.53</td>
<td>0.24</td>
<td>0.30</td>
<td>0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.75</td>
<td>0.53</td>
<td>0.29</td>
<td>0.16</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>0.0%</td>
<td>-1.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284179_0.png" alt="eps graph" /></p>
<h3>Tracking StealthGas's Stock Performance</h3>
<p>Shares of StealthGas were trading at $6.005 as of November 21. Over the last 52-week period, shares are down 11.17%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/GASS/earnings"><strong>To track all earnings releases for StealthGas visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GASS

Preview: StealthGas's Earnings

<p>Barclays  analyst Manav Patnaik   maintains Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) with a Underweight and raises the price target from $10 to $13.</p>


Price Target

Analyst Ratings

VSTS

Barclays Maintains Underweight on Vestis, Raises Price Target to $13

<p><strong>Boeing Co</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) has secured a $2.38 billion contract to build 15 additional KC-46A Pegasus tankers under the Lot 11 contract with the <a target="_blank" href="https://boeing.mediaroom.com/news-releases-statements?item=131508" rel="noreferrer noopener">U.S. Air Force</a>.</p>
<p>This latest award brings Boeing&#8217;s global contract to 168 KC-46A refuelers, a multi-mission aerial tanker designed to support advanced joint force capabilities.</p>
<p>The KC-46A has proven its operational value, having flown over 100,000 hours and offloading more than 200 million pounds of fuel worldwide.</p>
<p><strong><em>Also Read:</em></strong><em> <a target="_blank" href="https://www.benzinga.com/tech/24/11/42088437/qualcomm-targets-900-billion-market-by-2030-big-bets-on-iot-and-automotive" rel="noreferrer noopener">Qualcomm Targets $900 Billion Market by 2030: Big Bets on IoT and Automotive</a></em></p>
<p>It made its first full-scale deployment in October after being approved for global combat operations in 2022.</p>
<p>This contract builds on the July agreement, which focused on upgrading the KC-46A&#8217;s mission readiness and operational performance. Enhancements include advanced communication systems, improved data connectivity, and situational awareness, further strengthening survivability in contested environments. These upgrades complement the 2023 Block 1 improvements.</p>
<p>Since 2019, Boeing has delivered 89 Pegasus tankers to the U.S. Air Force and four to Japan&#8217;s Air Self-Defense Force. The KC-46A program continues to expand its reach, solidifying its role as a critical asset for U.S. and allied forces.</p>
<p>Boeing reported a 1% revenue decline to $17.85 billion in the&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41486950/boeing-q3-earnings-revenue-and-profit-decline-cultural-challenges-ceo-ortberg-vows-transformation" rel="noreferrer noopener">third quarter of 2024</a>, missing the analyst consensus of $17.93 billion. The adjusted operating loss of $5.99 billion, compared to $1.09 billion a year ago.&nbsp;</p>
<p>Last week, Boeing plans to fire <a target="_blank" href="https://www.benzinga.com/news/global/24/11/42052735/boeing-to-lay-off-over-2500-workers-in-the-us-amid-global-workforce-reduction" rel="noreferrer noopener">over 2,500 employees</a> in Washington, Oregon, South Carolina, and Missouri. This reduction is part of a larger effort to cut 17,000 jobs, representing 10% of the company&#8217;s global workforce.</p>
<p>In October, Boeing announced plans to raise <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41606547/boeing-eyes-20-7-billion-windfall-as-stock-offering-expands-details" rel="noreferrer noopener">$21 billion by</a> selling 112.5 million shares at $143.00 each and $5 billion in depositary shares.</p>
<p><strong>Price Action:</strong> BA stock is down 0.08% at $143.30 premarket at the last check Friday.</p>
<p><strong>Also Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/11/42092265/stmicroelectronics-targets-18-billion-revenue-eyes-22-24-margins-by-2028" target="_blank" rel="noreferrer noopener">STMicroelectronics Targets $20 Billion Revenue By 2030, Unveils 2027 Goals</a></strong></li>
</ul>
<p><em>Image via Shutterstock</em></p>


Contracts

Boeing Secures $2.38 Billion US Air Force Deal for Advanced KC-46A Tankers

<p>The U.S. economy could face a high-stakes, casino-like scenario in 2025, with risks swinging between a potential boom fueled by tax cuts and deregulation and a possible stagflationary bust triggered by policy <a href="https://www.benzinga.com/topic/donald-trump">uncertainty and trade restrictions. </a></p>
<p>This is the core message from JPMorgan&#8217;s chief economist, <strong>Michael Feroli</strong>, who laid out a sharply divided economic outlook shaped by the red sweep in the 2024 elections and the early policy indications from the incoming <strong>Donald Trump</strong> administration.</p>
<h3 class="wp-block-heading">Dueling Narratives For 2025: Economic Boom Or Stagflation</h3>
<p>In a note shared with clients earlier this week, Feroli presented competing narratives about the direction of the U.S. economy in 2025.</p>
<p>&#8220;One path sees tax cuts and deregulation unleashing animal spirits, thereby boosting productivity growth and GDP,&#8221; the economist wrote. </p>
<p>&#8220;The other path foresees policy uncertainty hindering growth, while trade and immigration restrictions impart a stagflationary bias,&#8221; he added.</p>
<p>Striking a balance between two extremes, JPMorgan projects a modest slowdown in growth to 2% in 2025, accompanied by a slight uptick in unemployment to 4.5%.</p>
<p>Feroli highlights that the U.S. Federal Reserve&#8217;s dual mandate of maximum employment and stable inflation faces a complex road ahead.</p>
<p>While inflation risks have moderated compared to two years ago, core PCE (the Fed&#8217;s preferred inflation gauge) remains stubbornly high, hovering in the upper 2% range. Simultaneously, the labor market is slowing but hasn&#8217;t bottomed in a way that assures confidence in avoiding further unemployment increases.</p>
<p>&#8220;Next year's outlook is cloudier than normal,&#8221; the investment bank wrote.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42136536/ark-invests-cathie-wood-says-team-trump-would-give-regulatory-clarity-for-bitcoin-and-other-digital-assets-which-they-may-put-in-the-treasurys-strategic-reserve">Ark Invest&#8217;s Cathie Wood Says Team Trump Would Give &#8216;Regulatory Clarity&#8217; For Bitcoin And Other Digital Assets: &#8216;&#8230;Which They May Put In The Treasury&#8217;s Strategic Reserve&#8217;</a></strong></p>
<h2 class="wp-block-heading"><strong>Policy and Tariff Risks on the Horizon</strong></h2>
<h3 class="wp-block-heading"><strong>Immigration and Labor Supply</strong></h3>
<p>Immigration policy is expected to take center stage in 2025 under the Trump administration. </p>
<p>A reduction in net immigration could significantly dampen labor supply growth, employment gains, and overall GDP expansion.</p>
<p>JPMorgan projects that immigration restrictions will tighten labor markets, potentially curbing economic growth over the long term.</p>
<p>Yet, they &#8220;don't anticipate immigration policy will have first-order effects on inflation.&#8221;</p>
<h3 class="wp-block-heading"><strong>Tariffs On China And Inflation Effects</strong></h3>
<p>On trade policy, JPMorgan assumes a 60% across-the-board tariff on Chinese imports will likely be implemented in 2025. </p>
<p>Tariffs on imports from other countries are expected to remain more limited in scope, though their potential introduction could further disrupt supply chains.</p>
<p>Currently, U.S. tariffs on Chinese goods stand at 11%. A steep increase to 60% would represent a dramatic escalation and could significantly strain the U.S.-China trade relationship. </p>
<p>While the broader economic impact is still uncertain, Feroli warns of inflationary pressures arising from such protectionist measures.</p>
<p>&#8220;Based on the volume of trade, the U.S. would be levying $215bn in taxes on Chinese imports and China would be levying just over $70bn in taxes on US exports,&#8221; he stated.</p>
<p>JPMorgan anticipates further progress toward the Fed&#8217;s 2% inflation target in 2025. </p>
<p>However, policies proposed by President-elect Trump, particularly higher tariffs on China, pose a risk of modestly higher inflation. The most significant impact is expected midyear, as increased tariffs could temporarily lift prices. </p>
<p>As a result, JPMorgan forecasts core PCE inflation to run at 2.3% by the end of 2025, before gradually aligning with the Fed&#8217;s 2% target in 2026.</p>
<h3 class="wp-block-heading"><strong>The Fiscal Deficit: A Growing Challenge</strong></h3>
<p>Fiscal policy is also under scrutiny, as the U.S. budget deficit is projected to expand significantly in the years ahead. </p>
<p>The Trump administration and a Republican-controlled Congress are expected to extend the 2017 Tax Cuts and Jobs Act (TCJA), whose personal income tax provisions are set to expire at the end of 2025.</p>
<p>&#8220;We expect essentially all the current tax code will be extended, which we project will mean a federal fiscal deficit of around 7% of GDP in 2026, at a time when we are at full employment and not directly involved in a war. The vagaries of the business cycle and geopolitics both skew risks toward a wider deficit,&#8221; Feroli said.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42130782/amazon-at-risk-of-major-fine-as-eu-investigates-alleged-preference-for-in-house-products-under-digital-markets-act-report"><strong>Amazon At Risk Of Major Fine As EU Investigates Alleged Preference For In-House Products Under Digital Markets Act: Report</strong></a></li>
</ul>
<p><em>Image created using artificial intelligence via Midjourney.</em></p>


Macro Economic Events

Econ #s

Economics

2025 US Economy Outlook 'Cloudier Than Normal,' JPMorgan Says: Boom, Bust Scenarios

<p><strong>Hesai Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) is set to give its latest quarterly earnings report on Monday, 2024-11-25. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Hesai Gr will report an <strong>earnings per share</strong> (EPS) of $-0.02. </p>
<p>The market awaits Hesai Gr's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.01, which was followed by a 7.95% drop in the share price the next day.</p>
<p>Here's a look at Hesai Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.06</td>
<td>-0.08</td>
<td>-0.11</td>
<td>-0.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.05</td>
<td>-0.08</td>
<td>-0.11</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>-14.000000000000002%</td>
<td>-4.0%</td>
<td>10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284151_0.png" alt="eps graph" /></p>
<h3>Tracking Hesai Gr's Stock Performance</h3>
<p>Shares of Hesai Gr were trading at $4.61 as of November 21. Over the last 52-week period, shares are down 56.63%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/HSAI/earnings"><strong>To track all earnings releases for Hesai Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


HSAI

Insights Ahead: Hesai Gr's Quarterly Earnings

<p><strong>Leslies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) is set to give its latest quarterly earnings report on Monday, 2024-11-25. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Leslies will report an <strong>earnings per share</strong> (EPS) of $0.11. </p>
<p>Anticipation surrounds Leslies's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.08, which was followed by a 14.49% increase in the share price the next day.</p>
<p>Here's a look at Leslies's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.42</td>
<td>-0.18</td>
<td>-0.21</td>
<td>0.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.34</td>
<td>-0.17</td>
<td>-0.20</td>
<td>0.14</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>14.000000000000002%</td>
<td>11.0%</td>
<td>2.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284143_0.png" alt="eps graph" /></p>
<h3>Market Performance of Leslies's Stock</h3>
<p>Shares of Leslies were trading at $2.87 as of November 20. Over the last 52-week period, shares are down 49.74%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/LESL/earnings"><strong>To track all earnings releases for Leslies visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LESL

A Look at Leslies's Upcoming Earnings Report

<p><strong>Semtech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) is set to give its latest quarterly earnings report on Monday, 2024-11-25. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Semtech will report an <strong>earnings per share</strong> (EPS) of $0.23. </p>
<p>Semtech bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.02 in the last quarter, leading to a 11.19% increase in the share price on the following day.</p>
<p>Here's a look at Semtech's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.09</td>
<td>0.11</td>
<td>-0.03</td>
<td>-0.13</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.11</td>
<td>0.06</td>
<td>-0.06</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>11.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>16.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284135_0.png" alt="eps graph" /></p>
<h3>Semtech Share Price Analysis</h3>
<p>Shares of Semtech were trading at $50.9 as of November 21. Over the last 52-week period, shares are up 210.74%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/SMTC/earnings"><strong>To track all earnings releases for Semtech visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SMTC

A Look at Semtech's Upcoming Earnings Report

<p>Agora (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>) is gearing up to announce its quarterly earnings on Monday, 2024-11-25. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Agora will report an <strong>earnings per share</strong> (EPS) of $-0.04.</p>
<p>Agora bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.01, leading to a 6.84% drop in the share price the following trading session.</p>
<p>Here's a look at Agora's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.070</td>
<td>-0.09</td>
<td>-0.09</td>
<td>-0.10</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.064</td>
<td>-0.05</td>
<td>0.01</td>
<td>-0.16</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>-11.0%</td>
<td>19.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284125_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Agora were trading at $4.56 as of November 21. Over the last 52-week period, shares are up 67.65%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/API/earnings"><strong>To track all earnings releases for Agora visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Agora

<p>Blue Bird (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) is preparing to release its quarterly earnings on Monday, 2024-11-25. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Blue Bird to report an <strong>earnings per share</strong> (EPS) of $0.67.</p>
<p>Anticipation surrounds Blue Bird's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company beat EPS by $0.40, which was followed by a 0.27% increase in the share price the next day.</p>
<p>Here's a look at Blue Bird's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.51</td>
<td>0.48</td>
<td>0.37</td>
<td>0.48</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.91</td>
<td>0.89</td>
<td>0.91</td>
<td>0.66</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>24.0%</td>
<td>-3.0%</td>
<td>10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284110_0.png" alt="eps graph" /></p>
<h3>Blue Bird Share Price Analysis</h3>
<p>Shares of Blue Bird were trading at $40.08 as of November 21. Over the last 52-week period, shares are up 117.47%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Blue Bird</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Blue Bird.</p>
<p>The consensus rating for Blue Bird is Buy, derived from 4 analyst ratings. An average one-year price target of $60.25 implies a potential 50.32% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of REV Group, Astec Industries and Wabash National, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>REV Group received a Buy consensus from analysts, with an average 1-year price target of $29.0, implying a potential 27.64% downside.</li>
<li>Astec Industries is maintaining an Neutral status according to analysts, with an average 1-year price target of $40.0, indicating a potential 0.2% downside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Wabash National, with an average 1-year price target of $18.0, indicating a potential 55.09% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>Within the peer analysis summary, vital metrics for REV Group, Astec Industries and Wabash National are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Blue Bird</td>
<td>Buy</td>
<td>13.28%</td>
<td>$69.35M</td>
<td>23.62%</td>
</tr>
<tr>
<td>REV Group</td>
<td>Buy</td>
<td>-14.79%</td>
<td>$78.30M</td>
<td>4.65%</td>
</tr>
<tr>
<td>Astec Industries</td>
<td>Neutral</td>
<td>-3.86%</td>
<td>$66.80M</td>
<td>-0.98%</td>
</tr>
<tr>
<td>Wabash National</td>
<td>Neutral</td>
<td>-26.67%</td>
<td>$56.01M</td>
<td>-87.93%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Blue Bird is positioned at the top for Revenue Growth and Gross Profit, outperforming its peers. However, it ranks lower for Return on Equity. Overall, Blue Bird shows strong growth potential compared to its peers in the industry.</p>
<h3>Get to Know Blue Bird Better</h3>
<p>Blue Bird Corp is an American bus manufacturing company. It has its operations in two segments. The Bus segment involves the design, engineering, manufacture and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. It carries its operations in the United States, Canada, and the rest of the world. The majority of its sales are derived from the United States through its bus manufacturing business.</p>
<h3>Key Indicators: Blue Bird's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Blue Bird's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of <strong>13.28%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Blue Bird's net margin excels beyond industry benchmarks, reaching <strong>8.61%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Blue Bird's ROE excels beyond industry benchmarks, reaching <strong>23.62%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Blue Bird's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>6.21%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Blue Bird's debt-to-equity ratio is below the industry average at <strong>0.71</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/BLBD/earnings"><strong>To track all earnings releases for Blue Bird visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BLBD

Examining the Future: Blue Bird's Earnings Outlook

IPOs

CASK

Heritage Distilling Prices $6.75M Initial Public Offering Of 1,687,500 Shares At $4.00/Share

Stock Split

CTXR

Citius Pharmaceuticals Announces 1-For-25 Reverse Stock Split Effective November 25, 2024, With Split-Adjusted Trading Starting November 26

<p>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) is preparing to release its quarterly earnings on Monday, 2024-11-25. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Fluence Energy to report an <strong>earnings per share</strong> (EPS) of $0.30.</p>
<p>The market awaits Fluence Energy's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.11 in the last quarter, leading to a 15.03% increase in the share price on the following day.</p>
<p>Here's a look at Fluence Energy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.11</td>
<td>-0.07</td>
<td>-0.13</td>
<td>-0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>-0.07</td>
<td>-0.14</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>15.0%</td>
<td>-8.0%</td>
<td>7.000000000000001%</td>
<td>24.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284064_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Fluence Energy were trading at $21.18 as of November 21. Over the last 52-week period, shares are up 10.89%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on Fluence Energy</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Fluence Energy.</p>
<p>With 7 analyst ratings, Fluence Energy has a consensus rating of Buy. The average one-year price target is $24.71, indicating a potential 16.67% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Atkore, Vicor and Sunrun, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>For Atkore, analysts project an Buy trajectory, with an average 1-year price target of $106.33, indicating a potential 402.03% upside.</li>
<li>Vicor received a Neutral consensus from analysts, with an average 1-year price target of $43.0, implying a potential 103.02% upside.</li>
<li>The consensus outlook from analysts is an Outperform trajectory for Sunrun, with an average 1-year price target of $20.65, indicating a potential 2.5% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Atkore, Vicor and Sunrun are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fluence Energy</td>
<td>Buy</td>
<td>-9.89%</td>
<td>$83.05M</td>
<td>0.19%</td>
</tr>
<tr>
<td>Atkore</td>
<td>Buy</td>
<td>-10.53%</td>
<td>$279.65M</td>
<td>7.78%</td>
</tr>
<tr>
<td>Vicor</td>
<td>Neutral</td>
<td>-13.61%</td>
<td>$45.74M</td>
<td>2.12%</td>
</tr>
<tr>
<td>Sunrun</td>
<td>Outperform</td>
<td>-4.62%</td>
<td>$103.48M</td>
<td>-1.57%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Fluence Energy ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity. Overall, Fluence Energy is positioned lower compared to its peers in terms of financial performance metrics.</p>
<h3>Get to Know Fluence Energy Better</h3>
<p>Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.</p>
<h3>Financial Insights: Fluence Energy</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Fluence Energy's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately <strong>-9.89%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Fluence Energy's net margin excels beyond industry benchmarks, reaching <strong>0.16%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Fluence Energy's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>0.19%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Fluence Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.05%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.13</strong>.</p>
<p><a href="https://www.benzinga.com/quote/FLNC/earnings"><strong>To track all earnings releases for Fluence Energy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


FLNC

Fluence Energy's Earnings Outlook

<p>In the last three months, 5 analysts have published ratings on Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Allegro Microsystems and provided 12-month price targets. The average target is $26.4, accompanied by a high estimate of $33.00 and a low estimate of $21.00. A 18.77% drop is evident in the current average compared to the previous average price target of $32.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284050_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The standing of Allegro Microsystems among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gary Mobley</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$23.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Moore</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>-</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$33.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Allegro Microsystems. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Allegro Microsystems compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Allegro Microsystems's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Allegro Microsystems's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALGM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Allegro Microsystems analyst ratings.</strong></a></p>
<h2>Get to Know Allegro Microsystems Better</h2>
<p>Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.</p>
<h3>Key Indicators: Allegro Microsystems's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Allegro Microsystems faced challenges, resulting in a decline of approximately <strong>-31.98%</strong> in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-17.97%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Allegro Microsystems's ROE excels beyond industry benchmarks, reaching <strong>-3.29%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Allegro Microsystems's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-2.29%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.45</strong>.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ALGM

A Closer Look at 5 Analyst Recommendations For Allegro Microsystems

<p>Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is preparing to release its quarterly earnings on Monday, 2024-11-25. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Woodward to report an <strong>earnings per share</strong> (EPS) of $1.25.</p>
<p>The announcement from Woodward is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.12, which was followed by a 17.17% drop in the share price the next day.</p>
<p>Here's a look at Woodward's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.51</td>
<td>1.32</td>
<td>1.10</td>
<td>1.31</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.63</td>
<td>1.62</td>
<td>1.45</td>
<td>0.84</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-17.0%</td>
<td>7.000000000000001%</td>
<td>-1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284048_0.png" alt="eps graph" /></p>
<h3>Market Performance of Woodward's Stock</h3>
<p>Shares of Woodward were trading at $172.54 as of November 21. Over the last 52-week period, shares are up 31.05%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Woodward</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Woodward.</p>
<p>The consensus rating for Woodward is Neutral, based on 2 analyst ratings. With an average one-year price target of $161.0, there's a potential 6.69% downside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of StandardAero, Rocket Lab USA and Leonardo DRS, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>StandardAero is maintaining an Outperform status according to analysts, with an average 1-year price target of $35.89, indicating a potential 79.2% downside.</li>
<li>The consensus among analysts is an Outperform trajectory for Rocket Lab USA, with an average 1-year price target of $13.75, indicating a potential 92.03% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Leonardo DRS, with an average 1-year price target of $34.0, suggesting a potential 80.29% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for StandardAero, Rocket Lab USA and Leonardo DRS, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Woodward</td>
<td>Neutral</td>
<td>5.87%</td>
<td>$229.99M</td>
<td>4.55%</td>
</tr>
<tr>
<td>StandardAero</td>
<td>Outperform</td>
<td>13.21%</td>
<td>$186.23M</td>
<td>1.42%</td>
</tr>
<tr>
<td>Rocket Lab USA</td>
<td>Outperform</td>
<td>54.90%</td>
<td>$28.00M</td>
<td>-11.87%</td>
</tr>
<tr>
<td>Leonardo DRS</td>
<td>Neutral</td>
<td>15.50%</td>
<td>$179M</td>
<td>2.34%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Woodward ranks in the middle for revenue growth among its peers. It is at the bottom for gross profit. Woodward is at the top for return on equity.</p>
<h3>Get to Know Woodward Better</h3>
<p>Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and service reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company holds production and assembly facilities primarily in the United States, Europe, and Asia, and promotes products and services through worldwide locations.</p>
<h3>Financial Milestones: Woodward's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Woodward showcased positive performance, achieving a revenue growth rate of <strong>5.87%</strong> as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Woodward's net margin is impressive, surpassing industry averages. With a net margin of <strong>12.04%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Woodward's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>4.55%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Woodward's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.35%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Woodward's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.44</strong>.</p>
<p><a href="https://www.benzinga.com/quote/WWD/earnings"><strong>To track all earnings releases for Woodward visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Woodward

<p>In the preceding three months, 10 analysts have released ratings for Bright Horizons Family (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFAM#NYSE">BFAM</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $137.7, a high estimate of $162.00, and a low estimate of $100.00. Marking an increase of 7.83%, the current average surpasses the previous average price target of $127.70. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284041_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Bright Horizons Family by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Jeffrey Silber</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$125.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Joshua Chan</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$148.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$162.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$149.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$108.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$131.00</td>
</tr>
<tr>
<td>Joshua Chan</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$145.00</td>
<td>$128.00</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$100.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Manav Patnaik</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bright Horizons Family. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Bright Horizons Family compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Bright Horizons Family's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Bright Horizons Family's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BFAM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Bright Horizons Family analyst ratings.</strong></a></p>
<h2>All You Need to Know About Bright Horizons Family</h2>
<p>Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.</p>
<h3>Financial Milestones: Bright Horizons Family's Journey</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Bright Horizons Family's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>11.35%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Bright Horizons Family's net margin is impressive, surpassing industry averages. With a net margin of <strong>7.64%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Bright Horizons Family's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>4.09%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.42%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Bright Horizons Family's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.32</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BFAM

The Analyst Landscape: 10 Takes On Bright Horizons Family

<p>9 analysts have expressed a variety of opinions on Cadence Design Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $310.56, a high estimate of $360.00, and a low estimate of $225.00. Surpassing the previous average price target of $303.00, the current average has increased by 2.5%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284033_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Cadence Design Sys by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$350.00</td>
<td>-</td>
</tr>
<tr>
<td>Gary Mobley</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$360.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$280.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Joe Vruwink</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$340.00</td>
<td>$332.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$315.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$325.00</td>
<td>-</td>
</tr>
<tr>
<td>Nay Soe Naing</td>
<td>Berenberg</td>
<td>Announces</td>
<td>Buy</td>
<td>$320.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$280.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Edward Yang</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Underperform</td>
<td>$225.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cadence Design Sys. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cadence Design Sys compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Cadence Design Sys's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Cadence Design Sys's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CDNS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Cadence Design Sys analyst ratings.</strong></a></p>
<h2>Get to Know Cadence Design Sys Better</h2>
<p>Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house semiconductor design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.</p>
<h3>Understanding the Numbers: Cadence Design Sys's Finances</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Cadence Design Sys's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>18.81%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Cadence Design Sys's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>19.59%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Cadence Design Sys's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>5.4%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Cadence Design Sys's ROA excels beyond industry benchmarks, reaching <strong>2.91%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>0.62</strong>, Cadence Design Sys faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Comments

Aphex BioCleanse Systems

News

Latest news for Aphex BioCleanse Systems (OTC:SNST) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga